Literature DB >> 16594952

Clinical neurological abnormalities in young adults with Asperger syndrome.

Pekka Tani1, Nina Lindberg, Björn Appelberg, Taina Nieminen-von Wendt, Lennart von Wendt, Tarja Porkka-Heiskanen.   

Abstract

Children with Asperger syndrome (AS), a neurodevelopmental disorder falling in the autism spectrum disorders, have an increased rate of neurological abnormalities, especially in motor coordination. While AS is a lifelong condition, little is known about the persistence of neurological abnormalities in adulthood. Twenty young adults with AS were compared with 10 healthy controls using a structured clinical neurological rating scale. The score for neurological abnormalities was higher in the AS group. In addition, a subscore for neurological soft signs indicating defective functioning of the central nervous system with a non-localizing value was significantly higher in the AS subjects. This preliminary study indicates that neurological abnormalities, soft signs in particular, represent a non-specific vulnerability factor for AS. Consistent with other features of AS, neurological abnormalities seem to persist into adulthood.

Entities:  

Mesh:

Year:  2006        PMID: 16594952     DOI: 10.1111/j.1440-1819.2006.01494.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  10 in total

Review 1.  Motor Abnormalities: From Neurodevelopmental to Neurodegenerative Through "Functional" (Neuro)Psychiatric Disorders.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

2.  Motor coordination in autism spectrum disorders: a synthesis and meta-analysis.

Authors:  Kimberly A Fournier; Chris J Hass; Sagar K Naik; Neha Lodha; James H Cauraugh
Journal:  J Autism Dev Disord       Date:  2010-10

3.  Neurological abnormalities and neurocognitive functions in healthy elder people: a structural equation modeling analysis.

Authors:  Raymond C K Chan; Ting Xu; Hui-jie Li; Qing Zhao; Han-hui Liu; Yi Wang; Chao Yan; Xiao-yan Cao; Yu-na Wang; Yan-fang Shi; Paola Dazzan
Journal:  Behav Brain Funct       Date:  2011-08-10       Impact factor: 3.759

4.  Finding behavioral and network indicators of brain vulnerability.

Authors:  Nava Levit-Binnun; Yulia Golland
Journal:  Front Hum Neurosci       Date:  2012-02-07       Impact factor: 3.169

5.  Sensory and motor secondary symptoms as indicators of brain vulnerability.

Authors:  Nava Levit-Binnun; Michael Davidovitch; Yulia Golland
Journal:  J Neurodev Disord       Date:  2013-09-24       Impact factor: 4.025

6.  Neurological abnormalities in recent-onset schizophrenia and asperger-syndrome.

Authors:  Dusan Hirjak; Robert Christian Wolf; Sabine C Koch; Laura Mehl; Janna K Kelbel; Katharina Maria Kubera; Tanja Traeger; Thomas Fuchs; Philipp Arthur Thomann
Journal:  Front Psychiatry       Date:  2014-08-06       Impact factor: 4.157

Review 7.  Autism, oxytocin and interoception.

Authors:  E Quattrocki; Karl Friston
Journal:  Neurosci Biobehav Rev       Date:  2014-09-30       Impact factor: 8.989

8.  Interactive Psychometrics for Autism With the Human Dynamic Clamp: Interpersonal Synchrony From Sensorimotor to Sociocognitive Domains.

Authors:  Florence Baillin; Aline Lefebvre; Amandine Pedoux; Yann Beauxis; Denis A Engemann; Anna Maruani; Frédérique Amsellem; J A Scott Kelso; Thomas Bourgeron; Richard Delorme; Guillaume Dumas
Journal:  Front Psychiatry       Date:  2020-11-26       Impact factor: 4.157

9.  Aripiprazole treatment of Asperger's syndrome in the acute psychiatric setting: case report.

Authors:  Luiz Dratcu; Gavin McKay; Vinod Singaravelu; Venkat Krishnamurthy
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

10.  Meta review of systematic and meta analytic reviews on movement differences, effect of movement based interventions, and the underlying neural mechanisms in autism spectrum disorder.

Authors:  Motohide Miyahara
Journal:  Front Integr Neurosci       Date:  2013-03-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.